AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 98.90
+0.40 (0.41%)
Jun 18, 2026, 1:30 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 8.46 billion as of June 18, 2026. Its market cap has increased by 85.17% in one year.
Market Cap
8.46B
Enterprise Value
7.42B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
98.90
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 8.46B, an increase of 66.09%. That is a compound annual growth rate of 18.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 8.46B | -44.76% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 11.74B |
| Tanvex BioPharma | 10.72B |
| ACRO Biomedical | 9.08B |
| Locus Cell | 8.60B |
| Gongwin Biopharm Holdings | 8.37B |
| PharmaEngine | 8.15B |
| Adimmune | 7.38B |
| Acepodia | 7.17B |